Naltrexone helps MS and other diseases? Hmmm...

I read quite a bit about Naltrexone, I read the information on the FDA site first then realized they weren't referencing the "low dose Naltrexone" used for treating people with HIV/AIDS, etc. I found a site called "Lowdosenaltrexone.org", I will post a clip about what they state in reference to the use of this drug for treating numerous diseases but I will also post the link to the page so the entire site can be accessed. I will also post the FDA's link for information about the drug. I would post more about what they state but the Neurontin has me in sleepyville. LOL!

Here's a bit of info about some of the diseases the http://www.lowdosenaltrexone.org/#What_is_low_dose_naltrexone site states the drug can effectively improve -

What diseases has it been useful for and how effective is it?

> Bernard Bihari, MD, as well as other physicians and researchers, have described beneficial effects of LDN on a variety of diseases:

Cancers
Bladder Cancer
Breast Cancer
Carcinoid
Colon & Rectal Cancer
Glioblastoma
Liver Cancer
Lung Cancer (Non-Small Cell)
Lymphocytic Leukemia (chronic)
Lymphoma (Hodgkin's and Non-Hodgkin's)
Malignant Melanoma
Multiple Myeloma
Neuroblastoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer (untreated)
Renal Cell Carcinoma
Throat Cancer
Uterine Cancer
Other Diseases
Common Colds (URI’s)
Emphysema (COPD)
HIV/AIDS
Autoimmune

Neurodegenerative:
ALS (Lou Gehrig's Disease)
Alzheimer's Disease
Autism Spectrum Disorders
Hereditary Spastic Paraparesis
Multiple Sclerosis (MS)
Parkinson's Disease
Primary Lateral Sclerosis (PLS)
Progressive Supranuclear Palsy
Transverse Myelitis

Other Autoimmune Diseases:
Ankylosing Spondylitis
Behcet's Disease
Celiac Disease
Chronic Fatigue Syndrome
CREST syndrome
Crohn's Disease
Dermatomyositis
Dystonia
Endometriosis
Fibromyalgia
Hashimoto’s Thyroiditis
Irritable Bowel Syndrome (IBS)
Myasthenia Gravis (MG)
Nephrotic Syndrome
Pemphigoid
Primary Biliary Cirrhosis
Psoriasis
Rheumatoid Arthritis
Sarcoidosis
Scleroderma
Sjogren’s Syndrome
Stiff Person Syndrome (SPS)
Systemic Lupus (SLE)
Ulcerative Colitis
Wegener's Granulomatosis

LDN has demonstrated efficacy in thousands of cases.

Cancer. As of mid-2004, Dr. Bihari reported having treated over 300 patients who had a cancer that had failed to respond to standard treatments. Of that group, some 50%, after four to six months treatment with LDN, began to demonstrate a halt in cancer growth and, of those, over one-third have shown objective signs of tumor shrinkage.

Autoimmune diseases. Within the group of patients who presented with an autoimmune disease (see above list), none have failed to respond to LDN; all have experienced a halt in progression of their illness. In many patients there was a marked remission in signs and symptoms of the disease. The greatest number of patients within the autoimmune group are people with multiple sclerosis, of whom there were some 400 in Dr. Bihari's practice. Less than 1% of these patients has ever experienced a fresh attack of MS while they maintained their regular LDN nightly therapy.

HIV/AIDS. As of September 2003, Dr. Bihari had been treating 350 AIDS patients using LDN in conjunction with accepted AIDS therapies. Over the prior 7 years over 85% of these patients showed no detectable levels of the HIV virus — a much higher success rate than most current AIDS treatments, and with no significant side effects. It is also worth noting that many HIV/AIDS patients have been living symptom-free for years taking only LDN with no other medications.

Central Nervous System disorders. Anecdotal reports continue to be received concerning beneficial effects of LDN on the course of Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS—Lou Gehrig’s disease), and primary lateral sclerosis. Dr. Jaquelyn McCandless has found a very positive effect of LDN, in appropriately reduced dosage and applied as a transdermal cream, in children with autism.

> How is it possible that one medication can impact such a wide range of disorders?

The disorders listed above all share a particular feature: in all of them, the immune system plays a central role. Low blood levels of endorphins are generally present, contributing to the disease-associated immune deficiencies.

Research by others — on neuropeptide receptors expressed by various human tumors — has found opioid receptors in many types of cancer:

Brain tumors (both astrocytoma and glioblastoma)
Breast cancer
Endometrial cancer
Head and neck squamous cell carcinoma
Myeloid leukemia
Lung cancer (both small cell and non-small cell)
Neuroblastoma and others...
These findings suggest the possibility for a beneficial LDN effect in a wide variety of common cancers.

The Low Dose Naltrexone Homepage

Naltrexone itself was approved by the FDA in 1984 in a 50mg dose for the purpose of helping heroin or opium addicts, by blocking the effect of such drugs. By blocking opioid receptors, naltrexone...

LOWDOSENALTREXONE.ORG